Pracinostat is a potent and orally active histone deacetylase (HDAC) inhibitor with high tumor exposure and efficacy in mouse models of colorectal cancer. The selectivity of Pracinostat for tumor tissues makes it a promising therapeutic candidate for use
分子图谱
暂无数据
点击上传数据
参考文献
• Novotny-Diermayr, V. et al.: Mol. Cancer Therap., 10, 1207 (2010)
• Novotny-Diermayr, V. et al.: Mol. Cancer Therap., 9, 642 (2010)
• Razak, A.R.A. et al.: Br. J. Cancer, 104, 756 (2010)